News and Events, Recent News

BriaCell Appoints Jamieson Bondarenko to its Board of Directors

BERKELEY, Calif., and VANCOUVER, British Columbia, February 12, 2019 – BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) (“BriaCell” or the “Company”), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, today announces the appointment of Jamieson Bondarenko to the Company’s Board of Directors. Jamieson Bondarenko, CFA, CMT, is an active investor and provides strategic capital […]